Baru nuts reduce abdominal adiposity in type 2 diabetic adults: a randomized, placebo-controlled crossover trial

被引：1
|
作者：
Cruvinel, Beatriz Assis Carvalho [1 ]
Alves, Ana Gabriella Pereira [2 ]
Schincaglia, Raquel Machado [3 ]
Silva, Maria Sebastiana [2 ]
机构：
[1] Univ Fed Jatai, Assuntos Estudantis, Jatai, GO, Brazil
[2] Univ Fed Goias, Fac Educ Fis & Danca, Lab Fisiol Nutr & Saude, Goiania, GO, Brazil
[3] Univ Fed Goias, Fac Med, Programa Posgrad Ciencias Saude, Goiania, GO, Brazil
来源：
REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION | 2023年 / 36卷
关键词：
Body composition; Diabetes Mellitus; Type 2. Dietary modification; Nuts; Obesity mangements; DIPTERYX-ALATA VOG; INSULIN-RESISTANCE; LIPID PROFILE; OBESE WOMEN; APPETITE; ALMOND; BIOACCESSIBILITY; METABOLISM; GLUCOSE; PLASMA;
D O I：
10.1590/1678-9865202336e220103
中图分类号：
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号：
100403 ;
摘要：
ObjectiveThis study aimed to evaluate the effect of baru nuts supplementation on body composition and metabolic profile in adults with type 2 diabetes. MethodsThis is a randomized, placebo-controlled, crossover trial with 30 adults with type 2 diabetes. The assay had two periods of 12 weeks each, with a washout period of 12 weeks between treatments. The subjects were randomized and received the two treatments in alternate periods: supplementation of 30g baru nuts or placebo. Anthropometry, body composition, blood pressure, blood sampling, food intake, and physical activity data were analyzed. ResultsBaru nut intake reduced waist circumference (p=0.032), compared to placebo group. In the intra-group analysis, baru nut intake reduced total cholesterol (p=0.012) and LDL-c (p=0.017). ConclusionThe daily intake of baru nuts improved abdominal adiposity. Therefore, these nuts should be included in the diet to improve the health status of adults with type 2 diabetes.
引用
收藏
页数：10
相关论文
共 50 条
  • [21] Metabolic health profile in young adults with Prader-Willi syndrome: results of a 2-year randomized, placebo-controlled, crossover GH trial
    Kuppens, R. J.
    Bakker, N. E.
    Siemensma, E. P. C.
    Donze, S. H.
    Stijnen, T.
    Hokken-Koelega, A. C. S.
    CLINICAL ENDOCRINOLOGY, 2017, 86 (02) : 297 - 304
  • [22] The effect of probiotic supplementation on glycemic control and lipid profile in patients with type 2 diabetes: A randomized placebo controlled trial
    Razmpoosh, Elham
    Javadi, Amir
    Ejtahed, Hanieh Sadat
    Mirmiran, Parvin
    Javadi, Maryam
    Yousefinejad, Abbas
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 175 - 182
  • [23] TOLRESTAT FOR MILD DIABETIC NEUROPATHY - A 52-WEEK, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    GIUGLIANO, D
    MARFELLA, R
    QUATRARO, A
    DEROSA, N
    SALVATORE, T
    COZZOLINO, D
    CERIELLO, A
    TORELLA, R
    ANNALS OF INTERNAL MEDICINE, 1993, 118 (01) : 7 - 11
  • [24] Effect of Bedtime Melatonin Administration in Patients with Type 2 Diabetes: A Triple-Blind, Placebo-Controlled, Randomized Trial
    Farrokhian, Amir
    Tohidi, Maryam
    Ahanchi, Noushin Sadat
    Khalili, Davood
    Niroomand, Mahtab
    Mahboubi, Arash
    Derakhshi, Arash
    Abbasinazari, Mohammad
    Hadaegh, Farzad
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 : 258 - 268
  • [25] Acute effect of Melon Manis Terengganu peel powder on glycemic response, perceived satiety, and food intake: a randomized, placebo-controlled crossover trial in adults at risk of type 2 diabetes
    Ong, Ying Qian
    Harith, Sakinah
    Shahril, Mohd Razif
    Shahidan, Norshazila
    Hapidin, Hermizi
    BMC NUTRITION, 2022, 8 (01)
  • [26] The hypoglycemic effects of Juglans regia L. internal septum in type 2 diabetic patients: A double-blind, randomized, placebo-controlled clinical trial
    Afra, Fatemeh
    Zargaran, Arman
    Shirzad, Nooshin
    Hemmatabadi, Mahboobeh
    Ebrahimpur, Mahbube
    Karimi, Mehrdad
    Khanavi, Mahnaz
    Mirshekari, Mehrzad
    Namazi, Soha
    JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, 2023, 15 (03) : 145 - 153
  • [27] The effect of vitamin K4 supplementation on insulin resistance in individuals with type 2 diabetes: a double-blind randomised placebo-controlled clinical trial
    Ali, Amani M. M.
    Abbassi, Maggie M. M.
    Sabry, Nirmeen A. A.
    Fawzi, May
    Mousa, Shrook
    EUROPEAN JOURNAL OF NUTRITION, 2023, 62 (08) : 3241 - 3249
  • [28] Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial
    Mooren, F. C.
    Krueger, K.
    Voelker, K.
    Golf, S. W.
    Wadepuhl, M.
    Kraus, A.
    DIABETES OBESITY & METABOLISM, 2011, 13 (03) : 281 - 284
  • [29] Anti-hyperglycemic and Anti-hyperlipidemic Effects of Lupinus albus in Type 2 Diabetic Patients: A Randomized Double-blind, Placebo-controlled Clinical Trial
    Bouchoucha, Rim
    Ben Fradj, Mohamed Kacem
    Bouchoucha, Mongia
    Akrout, Mouna
    Feki, Moncef
    Kaabachi, Naziha
    Raies, Aly
    Slimane, Hedia
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2016, 12 (08) : 830 - 837
  • [30] Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial
    Bo, S.
    Ponzo, V.
    Ciccone, G.
    Evangelista, A.
    Saba, F.
    Goitre, I.
    Procopio, M.
    Pagano, G. F.
    Cassader, M.
    Gambino, R.
    PHARMACOLOGICAL RESEARCH, 2016, 111 : 896 - 905
12345